SCHEMBL22722795

SCHEMBL22722795

c1ccc(-c2nc(-c3ccc(-c4cc(-c5ccccc5)c(-c5ccccc5)c(-c5ccccc5)c4-c4ccccc4)cc3)nc(-c3ccccc3-c3ccccc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.44
KMT2A Q03164 8/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
ADORA2A P29274 3/20 0.44
ADORA1 P30542 3/20 0.44
ADORA3 P0DMS8 2/20 0.44
ADORA2B P29275 2/20 0.44
TSHR P16473 2/20 0.44
ALOX15 P16050 1/20 0.44
GPR55 Q9Y2T6 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
NTSR1 P30989 1/20 0.41
LMNA P02545 4/20 0.39
KDM4E B2RXH2 2/20 0.39
GLA P06280 1/20 0.39
POLB P06746 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18180828 1.00 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22212990 0.95 ADORA2A (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22213054 0.93 ADORA2A (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18180834 0.93 ADORA2A (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22722688 0.93 ADORA2A (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22212988 0.93 ADORA2A (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18180855 0.93 ADORA2A (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22722741 0.93 ADORA2A (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22722744 0.93 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22722730 0.92 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2020-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus OXER1, OR10J3, AOX1 MEN1 2402/4885KMT2A 3536/4885MAPT 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.